Search

Your search keyword '"Asthma -- Care and treatment"' showing total 3,561 results
Start Over Descriptor "Asthma -- Care and treatment"
3,561 results on '"Asthma -- Care and treatment"'

51. Teva, Phil launch new program to improve access to Digihaler products

Subjects
Teva Pharmaceutical Industries Ltd., Generic drugs, Biological products, Pharmaceutical industry, Asthma -- Care and treatment, Business, News, opinion and commentary
Abstract

Phil announced an agreement with Teva Pharmaceuticals that will make Digihaler products available for prescription using the PhilRx Patient Access Platform. Teva's Digihaler system is the first and only smart [...]

Published
2023

52. 17 RESPIRATORY DISORDERS

Subjects
AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Corticosteroids
Abstract

17A Asthma/COPD >ADVAIR DISKUS 100/50 Rx GlaxoSmithKline Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2021

54. New clinical data from Arrowhead Pharmaceuticals demonstrates that ARO-RAGE achieves a high level of gene knockdown in asthmatic patients

Subjects
Arrowhead Pharmaceuticals Inc., Genetic research, Pharmaceutical industry, Asthma -- Care and treatment, General interest, News, opinion and commentary
Abstract

PASADENA: Arrowhead Pharmaceuticals, Inc., announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the [...]

Published
2024

56. EU Contract Notice: Szpital Miejski sw. Jana Pawla II w Elblagu Issues contract notice|solicitation for 'Open tender procedure for the purchase of drugs under the drug program - treatment of patients with severe asthma (B.44)'

Subjects
Drugs, Asthma -- Care and treatment, Contract agreement, Business, international
Abstract

Luxembourg: Szpital Miejski sw. Jana Pawla II w Elblagu has issued contract notice/solicitation for 'Open tender procedure for the purchase of drugs under the drug program - treatment of patients [...]

Published
2024

57. SpliSense Announces FDA Clearance of Investigational New Drug Application for Phase 2 Initiation of SPL84 for the Treatment of Cystic Fibrosis

Subjects
United States. Food and Drug Administration, Cystic fibrosis -- Care and treatment, RNA, Asthma -- Care and treatment, Business, News, opinion and commentary
Abstract

- Funding secured from CF Foundation and current investors for SPL84 Phase 2 study - - Two additional early-stage candidates expected to commence Phase 1-2a studies over the next 12 [...]

Published
2024

58. Researchers from National Research Center Institute of Immunology Detail Findings in Nasal Polyps (Personalized approach to the biologicals selection and therapy in patients with asthma and chronic rhinosinusitis with nasal polyps: clinical ...)

Subjects
Care and treatment, Nasal polyps -- Care and treatment, Monoclonal antibodies, Asthma -- Care and treatment
Abstract

2024 AUG 26 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Data detailed on nasal polyps have been presented. According to news originating from Moscow, [...]

Published
2024

59. China Medical University and Hospital Researchers Describe Research in Asthma (Comparison of Budesonide/formoterol versus Fluticasone furoate/vilanterol as maintenance and reliever therapy for asthma control: a real-world observational study)

Subjects
Care and treatment, Comparative analysis, Anti-inflammatory agents -- Comparative analysis, Pitchers (Baseball) -- Comparative analysis, Asthma -- Care and treatment, Vilanterol -- Comparative analysis, Anti-inflammatory drugs -- Comparative analysis
Abstract

2024 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators discuss new findings in asthma. According to news reporting originating from China Medical [...]

Published
2024

60. Universidad de Concepcion Researcher Highlights Recent Research in Artificial Intelligence (A Technological Framework to Support Asthma Patient Adherence Using Pictograms)

Subjects
Care and treatment, Artificial intelligence, Machine learning, Natural language processing, Patient compliance, Asthma -- Care and treatment, Natural language interfaces, Computational linguistics, Language processing
Abstract

2024 AUG 16 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on artificial intelligence have been published. According to news reporting [...]

Published
2024

61. Study Findings on Biologics Detailed by Researchers at Korea University (Comparative efficacy of biologics for patients with inadequately controlled asthma: A network meta-analysis)

Subjects
Korea University -- Reports, Care and treatment, Reports, Comparative analysis, Monoclonal antibodies -- Comparative analysis -- Reports, Asthma -- Care and treatment
Abstract

2024 AUG 5 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators publish new report on biologics. According to news originating from Sejong, South Korea, [...]

Published
2024

62. Researchers at Northern Health and Social Care Trust Zero in on Digital Technology (Service development project to pilot a digital technology innovation for video direct observation of therapy in adult patients with asthma)

Subjects
Care and treatment, Innovations, Respiratory system agents, Asthma -- Care and treatment, Respiratory agents
Abstract

2024 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- A new study on digital technology is now available. According to news originating from [...]

Published
2024

63. New Chronic Obstructive Pulmonary Disease Findings from Woolcock Institute of Medicine Research Described (Advances In Inhaler Therapy for Asthma and Chronic Obstructive Pulmonary Disease: a Comprehensive Review of Fostair and Trimbow)

Subjects
Care and treatment, Diseases -- Care and treatment -- Australia, Respiratory system agents, Medical research, Asthma -- Care and treatment, Medicine, Experimental, Respiratory agents
Abstract

2024 JUL 29 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Investigators discuss new findings in Lung Diseases and Conditions - Chronic Obstructive Pulmonary Disease. [...]

Published
2024

66. Researchers from Aarhus University Report New Studies and Findings in the Area of Asthma (Adherence To Guidelines Prior To Endoscopic Sinus Surgery In Patients With Chronic Rhinosinusitis and Asthma)

Subjects
Aarhus University -- Reports, Care and treatment, Reports, Patient compliance -- Reports, Asthma -- Care and treatment
Abstract

2024 JUN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Data detailed on Lung Diseases and Conditions - Asthma have been [...]

Published
2024

67. Investigators at AstraZeneca Report Findings in Asthma (Efficacy of Tezepelumab In Patients With Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups In the Navigator Study)

Subjects
Care and treatment, Reports, Dupilumab -- Reports, Immunotherapy -- Reports, Asthma -- Care and treatment
Abstract

2024 JUN 19 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on Lung Diseases and Conditions - Asthma. According to news reporting [...]

Published
2024

68. New Findings on Asthma from GlaxoSmithKline plc Summarized (A Network Meta-analysis of the Association Between Patient Traits and Response To Regular Dosing With Ics Plus Short-acting 82-agonist Reliever or Ics/formoterol Reliever Only In Mild ...)

Subjects
GSK PLC, Care and treatment, Pitchers (Baseball), Respiratory system agents, Medical research, Pharmaceutical industry, Asthma -- Care and treatment, Medicine, Experimental, Respiratory agents
Abstract

2024 JUN 17 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Researchers detail new data in Lung Diseases and Conditions - Asthma. According to news [...]

Published
2024

69. Research from Karolinska Institute in Anxiety Disorders Provides New Insights (Internet-delivered cognitive-behaviour therapy for anxiety related to asthma: study protocol for a randomised controlled trial)

Subjects
Care and treatment, Clinical trials, Behavioral medicine, Anxiety -- Care and treatment, Asthma -- Care and treatment, Cognitive-behavioral therapy, Cognitive therapy, Behavioral health care
Abstract

2024 JUN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in anxiety disorders. According to news reporting out of [...]

Published
2024

71. GSK to buy asthma drug maker Aiolos for PS1.1bn

Subjects
Biological products -- Planning, Antiasthmatic agents -- Planning, Asthma -- Care and treatment, Pharmaceutical industry -- Mergers, acquisitions and divestments, Company business planning, Company acquisition/merger, Business, General interest
Abstract

Byline: PHARMACEUTICALS Simon Hunt THE first major takeover of 2024 sparked life into London's M&A market today when pharma g iant GSK unveiled plans to buy asthma drug maker Aiolos [...]

Published
2024

72. Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?

Author

Faruqi, Shoaib, Sykes, Dominic L., Crooks, Michael G., Brindle, Kayleigh, Thompson, Joanne, and Morice, Alyn H.

Subjects
Care and treatment, Ivacaftor, Asthma -- Care and treatment
Abstract

Author(s): Shoaib Faruqi [sup.1], Dominic L. Sykes [sup.1], Michael G. Crooks [sup.1], Kayleigh Brindle [sup.1], Joanne Thompson [sup.1], Alyn H. Morice [sup.1] Author Affiliations: (1) grid.9481.4, 0000 0004 0412 8669, [...], Cough is an important symptom of asthma. The objective assessment of chronic cough has been enhanced by the development of ambulatory cough monitoring systems. Mepolizumab has been demonstrated to reduce exacerbations in eosinophilic asthmatics long-term. We evaluate the utility of objective cough count as an outcome measure in severe eosinophilic asthma treated with mepolizumab. Consecutive, consenting patients initiated on treatment with mepolizumab had a 24-h cough count recorded at baseline; this was repeated at 1, 3 and 6 months. Asthma control questionnaire (ACQ) scores and exacerbation frequency were also recorded. The mean 24-h cough count in 11 subjects (8 females, mean age 53.6 years) was 172.4 at baseline; at 1, 3 and 6 months following initiation of treatment this decreased to 101.4, 92 and 70.8, respectively (p < 0.02). Significant improvements were also observed in mean ACQ score (3-1.6, p < 0.01) and exacerbation frequency (5.5 per year - 1.3, p < 0.01). Objective cough measurement could be used as an early, precise and clinically relevant endpoint in assessing response to asthma therapy.

Published
2020
Full Text
View/download PDF

73. Teva buys rights for Israeli co Biolojic's asthma treatment

Subjects
Teva Pharmaceutical Industries Ltd., Respiratory agents, Atopic dermatitis -- Care and treatment, Asthma -- Care and treatment, Business, General interest, Business, regional
Abstract

Byline: Gali Weinreb Dec. 14Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Israeli company Biolojic Design have signed a collaboration agreement. Teva will complete development of Biolojic's antibody-based therapy [...]

Published
2023

76. University of Vermont Researcher Details New Studies and Findings in the Area of Ketosis (Therapeutic ketosis decreases methacholine hyperresponsiveness in mouse models of inherent obese asthma)

Subjects
Testing, Care and treatment, Obesity -- Care and treatment, Methacholine -- Testing, Asthma -- Care and treatment
Abstract

2023 APR 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in ketosis. According to news reporting originating from [...]

Published
2023

77. University of Florida Researchers Target Asthma (214 A TL1 Team Approach: Physician Strategies to Promote Physical Activity Among Youth with Comorbid Asthma and Overweight/Obesity)

Subjects
Care and treatment, Social aspects, Research, Methods, Health aspects, Pediatric research, Adolescent obesity -- Care and treatment, Comorbid patients -- Care and treatment, Asthma -- Care and treatment, Exercise -- Social aspects -- Health aspects, Health promotion -- Methods, Physician-patient relations -- Research, Obesity in adolescence -- Care and treatment, Physician and patient -- Research
Abstract

2023 APR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on asthma. According to news reporting originating from [...]

Published
2023

79. 13 RESPIRATORY DISORDERS

Subjects
Merck & Company Inc., AstraZeneca PLC, Mucinex (Medication), Advair Diskus (Medication), Care and treatment, Atazanavir, Fluticasone, Glucocorticoids, Pharmaceutical industry, Asthma -- Care and treatment, Ciclesonide, Vilanterol, Corticosteroids
Abstract

13A Asthma/COPD >ADVAIR DISKUS 100/50 GlaxoSmithKline Rx Corticosteroid + long-acting beta-2 agonist (LABA). Fluticasone propionate 100mcg, salmeterol (as xinafoate) 50mcg; per inh; dry pwd for inh. Also: ADVAIR DISKUS 500/50 [...]

Published
2021

80. New Findings in Coronavirus Described from Mansoura University (Isocratic ion pair chromatography for estimation of novel combined inhalation therapy that blocks coronavirus replication in chronic asthmatic patients)

Subjects
Care and treatment, Analysis, Physical fitness -- Analysis, Tiotropium -- Analysis, Coronaviruses -- Analysis, Chromatography -- Analysis, Journalistic ethics -- Analysis, Asthma -- Care and treatment, Ciclesonide -- Analysis
Abstract

2023 JAN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in coronavirus. According to news reporting from Mansoura [...]

Published
2023

82. Fixed-Dose Combo Airsupra Approved as Rescue Therapy for Asthma

Author

Park, Brian

Subjects
United States. Food and Drug Administration, Care and treatment, Dosage and administration, Drug approval, Asthma -- Care and treatment
Abstract

The Food and Drug Administration (FDA) has approved Airsupra (albuterol/budesonide) for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients 18 years of [...]

Published
2023

83. Reports from Instituto Politecnico Nacional Describe Recent Advances in Asthma (Role of Sulfur Compounds in Garlic as Potential Therapeutic Option for Inflammation and Oxidative Stress in Asthma)

Subjects
Care and treatment, Physical fitness, Sulfur, Inflammation -- Care and treatment, Oxidative stress -- Care and treatment, Sulfur compounds, Asthma -- Care and treatment
Abstract

2023 JAN 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in asthma. According to news originating from Mexico [...]

Published
2023

84. National Research Council (NRC) Researchers Update Knowledge of Formoterol Therapy (Validation of a simplified-geometry model of inhaled formoterol pharmacodynamics in asthmatic patients)

Subjects
National Research Council, Care and treatment, Analysis, Physical fitness -- Analysis, Asthma -- Care and treatment
Abstract

2022 DEC 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on formoterol therapy have been published. According to news [...]

Published
2022

85. Reports from National Chung Hsing University Advance Knowledge in Asthma (Lactoferrin Ameliorates Ovalbumin-Induced Asthma in Mice through Reducing Dendritic-Cell-Derived Th2 Cell Responses)

Subjects
Care and treatment, Research, Health aspects, Respiratory system agents -- Research, Dendritic cells -- Health aspects, Lactoferrin -- Health aspects, Therapeutics research, Asthma -- Care and treatment, Immune response -- Research, T cells -- Health aspects, Respiratory agents -- Research, Therapeutics, Experimental, Lactoferrins -- Health aspects
Abstract

2022 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on asthma. According to news originating from Taichung, [...]

Published
2022

86. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

87. Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024

Subjects
Omalizumab -- Product development, Immunoglobulin E, Asthma -- Care and treatment, Business, News, opinion and commentary
Abstract

WASHINGTON, Feb. 25, 2024 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (referred to as 'Longbio Pharma'), a leading biotech company dedicated to developing innovative protein treatments for allergy, respiratory, dermatology, [...]

Published
2024

88. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

89. MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA

Subjects
AstraZeneca PLC -- Product development, Clinical trials, Pharmaceutical industry -- Product development, Asthma -- Care and treatment, Business, Business, international, American Academy of Allergy, Asthma and Immunology
Abstract

FASENRA enabled patients to taper off oral corticosteroids while preventing relapses WILMINGTON, Del. -- Positive results from the MANDARA Phase III trial for FASENRA([R]) (benralizumab) in patients with EGPA were [...]

Published
2024

90. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

91. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

92. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

93. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

94. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

95. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

96. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

97. Intrommune Therapeutics To Attend A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Subjects
Immunotherapy, Conferences and conventions, Food allergy -- Care and treatment, Asthma -- Care and treatment, General interest, News, opinion and commentary
Abstract

NEW YORK: Intrommune Therapeutics, Inc., announces data from The First Study To Evaluate Oral Mucosal Immunotherapy For The Treatment Of Food Allergy has been selected as a Late Breaking Poster [...]

Published
2024

98. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

99. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

100. Occupational asthma

Subjects
United States. Occupational Safety and Health Administration, Care and treatment, Disease susceptibility -- Care and treatment, Asthma -- Care and treatment
Abstract

Overview Asthma is a condition in which your airways narrow and swell and may produce extra mucus. Occupational asthma is a type of asthma. It occurs when you breathe in [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results